SI
TRIB

Stephens Inc’s Trinity Biotech TRIB Stock Holding History

Stephens Inc’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,820
Closed -$201K – 868
2016
Q4 		$201K Sell
5,820
-8,119
-58% -$280K 0.01% 717
2016
Q3 		$921K Sell
13,939
-2,129
-13% -$133K 0.04% 384
2016
Q2 		$911K Sell
16,068
-11,837
-42% -$667K 0.04% 372
2016
Q1 		$1.63M Buy
27,905
+3,271
+13% +$174K 0.08% 265
2015
Q4 		$1.45M Buy
24,634
+1,009
+4% +$59.5K 0.07% 273
2015
Q3 		$1.35M Buy
+23,625
New +$1.9M 0.07% 281

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Stephens Inc's TRIB Position: Q1 2017 in Review

Stephens Inc sold out of Trinity Biotech (TRIB) in Q1 2017, closing a stake of 5,820 shares — an estimated $201K sold.

Stephens Inc first reported a position in TRIB in Q3 2015 and held it in 6 quarters. The position peaked at $1.63M in Q1 2016. 67 funds tracked by Wall St. Rank hold TRIB as of Q1 2017.

  • Stephens Inc reported no remaining Trinity Biotech position as of Q1 2017 after selling out during the quarter.
  • Stephens Inc sold 5,820 Trinity Biotech shares in Q1 2017, an estimated $201K.
  • Stephens Inc first reported a position in Trinity Biotech in Q3 2015 and held it in 6 quarters.
  • Stephens Inc's Trinity Biotech position peaked at $1.63M in Q1 2016.
  • 67 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2017.

Based on Stephens Inc's 13F filing for Q1 2017, filed 11 May 2017.